Product Details
Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection Prefilled Syringe 3 mL
Manufacturer: FIDIA PHARMA US
MFG#: 89122-0496-01
NDC: 89122-0496-01
PID: 418044
1/PK
$ *.**
Limited QuantitiesAdditional Information
| Product Name | Hymovis® Hyaluronate, Modified, Non-Crosslinked 8 Mg / Ml Injection Prefilled Syringe 3 Ml |
| Application | Osteoarthritis Agent |
| Dosage Form | Injection |
| Generic Drug Name | Hyaluronate, Modified, Non-Crosslinked |
| Mechanism of Action | Restores viscosity and elasticity to synovial fluid, improving joint lubrication and reducing pain in osteoarthritis |
| Strength | 8 mg / mL |
| Volume | 3 mL |
| Route of Administration | Intra-articular |
| Side Effects | Pain, swelling, or redness at the injection site; rare allergic reactions |
| Contraindications | Known hypersensitivity to hyaluronate |
| Container Type | Prefilled Syringe |
| Storage Requirements | Store at room temperature, 20-25°C (68-77°F); avoid freezing |
| Uses | Provides symptomatic relief from osteoarthritis pain, improving joint mobility and function |
Description
HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel formulated with modified, non-crosslinked hyaluronate, indicated for the treatment of pain associated with osteoarthritis (OA) of the knee. This injectable formulation is designed to restore the viscosity and elasticity of the synovial fluid, which is often reduced in patients suffering from OA.
The product comes in a prefilled syringe containing a 3 mL dose. Each syringe is single-use only, ensuring sterile administration. HYMOVIS® works by replenishing the hyaluronic acid in the knee joint, which may help improve the lubrication and cushioning of the joint, resulting in pain relief and enhanced movement.
HYMOVIS® has a viscoelastic property, allowing it to mimic the natural synovial fluid within the knee joint. By improving the viscosity, it facilitates smoother joint movement, helping to alleviate the discomfort and limitations associated with osteoarthritis. It does not alter the underlying disease but targets the symptoms.
Product Properties:
| Description | - |
|---|---|
| Description | Hymovis inj, 1 mg |
| DESI Drug Ind | - |
| DESI Drug Ind | -; - |
| DESI2 Drug Ind | - |
| Drug Category | - |
| Drug Type Code | - |
| FDA Approval Date | - |
| FDA Therap Equiv | - |
| HCPCS | - |
| HCPCS | J7322 |
| Market Entry Date | - |
| Medical Coverage | COVERED WITH CARRIER DISCRETION |
| Medical Coverage | - |
| Termination Date | - |
| Unit | - |
| Units Per Pkg | - |
| Active Ingredients | 16225 hyaluronate sodium, modified, non-crosslinked |
| Active Ingredients | 16225 hyaluronate sodium, modified, non-crosslinked |
| AHFS Class | 94000000 DEVICES |
| AHFS Class | 94000000 DEVICES |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | SYRINGE (ML) |
| Dose Form | SYRINGE (ML) |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 74366 hyaluronate,mod.,non-crosslink INTRAARTIC SYRINGE 24 MG/3 ML |
| Gen Code and Des | 74366 hyaluronate,mod.,non-crosslink INTRAARTIC SYRINGE 24 MG/3 ML |
| Inactive Ingredients | - |
| Inactive Ingredients | - |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 24MG |
| Strength | 24MG |
| Common Brand Name | J7322 |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 140 |
| Case Quantity | 140 |
| Drug Form Pack Size | 3 |
| Drug Form Pack Size | 3 |
| Form | PRE-FILLED SYRINGE |
| Form | PRE-FILLED SYRINGE |
| Hazard Code | - |
| Hazard Code | - |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | - |
| NIOSH Code | - |
| Orange Book | ZB Particular pharmaceutical entity was not evaluated. |
| Orange Book | ZB Particular pharmaceutical entity was not evaluated. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit Size | 3 |
| Unit Size | 3 |
| How to Use | - |
| Missed Dose | - |
| Notes | - |
| Overdose | - |
| Phonetic Pronunciation | COVERED WITH CARRIER DISCRETION |
| Precautions | - |
| Side Effects | - |
| Storage | - |
| Uses | Hymovis inj, 1 mg |
Frequently Asked Questions (FAQs)
The cost of Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection Prefilled Syringe 3 mL is $$0.00
Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection Prefilled Syringe 3 mL is manufactured by FIDIA PHARMA US.
You can purchase Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection Prefilled Syringe 3 mL on our website at https://supplies.pipelinemedical.com/product/detail/hymovis-24-mg-pfs-3-ml-239712